Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Shakes Up R&D, Closes Nutley Operations

This article was originally published in The Pink Sheet Daily

Executive Summary

Roche will shut down its Nutley, N.J., pharma operations – once its U.S. headquarters – by the end of 2013 in a cost-saving measure that will leave only a small group of employees on the East Coast.

Advertisement

Related Content

Roche Reviews Its Research Priorities With Opening Of Translational Research Center
Roche Opens NY R&D Hub As Its pRED Head Vows To Boost Alliances
Roche CEO Severin Schwan: Fueled By Innovation, Emerging Markets
Roche Taps Scientific Heavyweight John Reed To Head Early Pharma R&D
“The Pink Sheet” DAILY – Most Notable Stories Of 2012
Research And Early Development At Roche, A Work In Progress: An Interview With Mike Burgess
Roche’s New Pharma Head Vows To Expand Development Of Targeted Therapies
With Perjeta, The Cost Of HER2 Breast Cancer Therapy Goes Up
Dalcetrapib Failure Raises Yet More Questions On Value Of Tinkering With HDL Cholesterol
Roche Wins Genentech After Months-Long Battle

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel